12,7500 zł
-1,92% -0,2500 zł
SOPHARMA AD (SPH)

Komunikaty spółki - SOPHARMA

NOTIFICATION OF INSIDERS’ TRANSACTIONS under art. 19 of Regulation 596/2014 for subscribin shares from a temporary issue/exercising warrants
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 as of 20 February 2024 re exercising warrants
Notification from Ognian Donev under Art. 19 of Regulation (EU) 596/2014 for subscribing sharesd form a temporary issue/exercising warrants on 19 February 2024
Notification from Ognian Donev in accordance with art. 19 from Regulation 596/2014 for exercising warrants on 19 February 2024
Notification for Sales revenues for January 2024
Technical error in the Notification under Art. 89t of the Law on Public Offering of Securities published on 26.01.2024
Individual financial report according to IFRS as of 31 December 2023
Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exercising warrants from the issue with ISIN BG9200001212
Sopharma AD-Sofia presented Мinutes of the General Meeting of Warrant Holders held on 26-01-2024 11:00 a.m
Sales revenues for December 2023
Presentation of materials and Invitation for General Meeting of Warrant holders of Sopharma AD
Merger of the subsidiary "Veta pharma" AD into "Sopharma" AD
"Sopharma" AD starts the payment of the dividend for the 6 months of 2023 on January 22, 2024
Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 22 December 2023
Notification for Buy-back of treasury shares
Przejdź do strony za 5 Przejdź do strony »

Czy wiesz, że korzystasz z adblocka?
Reklamy nie są takie złe

To dzięki nim możemy udostępniać
Ci nasze treści.